AUSTAR Posts March 2026 Monthly Return: Share Capital Unchanged, Public Float Compliant

Bulletin Express04-01

Austar Lifesciences Limited (AUSTAR) filed its monthly return for the period ended 31 March 2026 with Hong Kong Exchanges and Clearing Limited on 1 April 2026. The disclosure shows stable equity metrics and continued adherence to public-float requirements.

The company’s authorised share capital remained at 10.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 100.00 million. No changes were recorded during the month.

Issued share capital also held steady. Outstanding ordinary shares totalled 512.58 million, with no treasury shares on the balance sheet. Consequently, total issued shares were unchanged at 512.58 million.

AUSTAR confirmed compliance with Main Board Rule 13.32D(1), maintaining a public float above the 25 % threshold mandated for its share class.

The filing reports no movements related to share options, warrants, convertible instruments, other equity-linked agreements, or Hong Kong Depositary Receipts during March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1157604518?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-01 11:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157604518","market":"hk","top_or_hot":-1,"title":"AUSTAR Posts March 2026 Monthly Return: Share Capital Unchanged, Public Float Compliant","media":"Bulletin Express","content":"<p>Austar Lifesciences Limited (AUSTAR) filed its monthly return for the period ended 31 March 2026 with Hong Kong Exchanges and Clearing Limited on 1 April 2026. The disclosure shows stable equity metrics and continued adherence to public-float requirements.</p>\n<p>The company’s authorised share capital remained at 10.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 100.00 million. No changes were recorded during the month.</p>\n<p>Issued share capital also held steady. Outstanding ordinary shares totalled 512.58 million, with no treasury shares on the balance sheet. Consequently, total issued shares were unchanged at 512.58 million.</p>\n<p>AUSTAR confirmed compliance with Main Board Rule 13.32D(1), maintaining a public float above the 25 % threshold mandated for its share class.</p>\n<p>The filing reports no movements related to share options, warrants, convertible instruments, other equity-linked agreements, or Hong Kong Depositary Receipts during March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AUSTAR Posts March 2026 Monthly Return: Share Capital Unchanged, Public Float Compliant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAUSTAR Posts March 2026 Monthly Return: Share Capital Unchanged, Public Float Compliant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-01 11:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Austar Lifesciences Limited (AUSTAR) filed its monthly return for the period ended 31 March 2026 with Hong Kong Exchanges and Clearing Limited on 1 April 2026. The disclosure shows stable equity metrics and continued adherence to public-float requirements.</p>\n<p>The company’s authorised share capital remained at 10.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 100.00 million. No changes were recorded during the month.</p>\n<p>Issued share capital also held steady. Outstanding ordinary shares totalled 512.58 million, with no treasury shares on the balance sheet. Consequently, total issued shares were unchanged at 512.58 million.</p>\n<p>AUSTAR confirmed compliance with Main Board Rule 13.32D(1), maintaining a public float above the 25 % threshold mandated for its share class.</p>\n<p>The filing reports no movements related to share options, warrants, convertible instruments, other equity-linked agreements, or Hong Kong Depositary Receipts during March 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06118","symbol_name":"奥星生命科技","start_time":0,"source_url":"","article_id":"1157604518","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157604518","pubTimestamp":1775015097,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Austar Lifesciences Limited (AUSTAR) filed its monthly return for the period ended 31 March 2026 with Hong Kong Exchanges and Clearing Limited on 1 April 2026. The disclosure shows stable equity...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06118":"奥星生命科技"},"translate_title":"奥星发布2026年3月月报表：股本不变，公众持股量合规","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06118":1},"content_text":"Austar Lifesciences Limited (AUSTAR) filed its monthly return for the period ended 31 March 2026 with Hong Kong Exchanges and Clearing Limited on 1 April 2026. The disclosure shows stable equity metrics and continued adherence to public-float requirements.\nThe company’s authorised share capital remained at 10.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 100.00 million. No changes were recorded during the month.\nIssued share capital also held steady. Outstanding ordinary shares totalled 512.58 million, with no treasury shares on the balance sheet. Consequently, total issued shares were unchanged at 512.58 million.\nAUSTAR confirmed compliance with Main Board Rule 13.32D(1), maintaining a public float above the 25 % threshold mandated for its share class.\nThe filing reports no movements related to share options, warrants, convertible instruments, other equity-linked agreements, or Hong Kong Depositary Receipts during March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1157604518","isCrawlerRequest":true}